3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Melanoma
7
Ovarian Neoplasms
6
Pancreatic Neoplasms
4
Carcinoma, Renal Cell
4
Carcinoma, Non-Small-Cell Lung
4
Breast Neoplasms
4
Urogenital Neoplasms
3
Stomach Neoplasms
3
Neoplasm Metastasis
3
Leukemia, Myeloid, Acute
3
Gastrointestinal Neoplasms
3
Triple Negative Breast Neoplasms
2
Squamous Cell Carcinoma of Head and Neck
2
Skin Neoplasms
2
Rectal Neoplasms
2
Multiple Myeloma
2
Colorectal Neoplasms
2
Colonic Neoplasms
2
Carcinoma, Squamous Cell
2
Urinary Bladder Neoplasms
1
Thyroid Carcinoma, Anaplastic
1
Sarcoma
1
Recurrence
1
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Pleural Effusion, Malignant
1
Osteosarcoma
1
Neuroendocrine Tumors
1
Neuroblastoma
1
Myelodysplastic Syndromes
1
Interventions
Cyclophosphamide
7
fludarabine phosphate
6
Whole-Body Irradiation
6
Busulfan
5
Peripheral Blood Stem Cell Transplantation
4
Mycophenolic Acid
4
Melphalan
4
Azacitidine
4
venetoclax
3
fludarabine
3
Tacrolimus
3
Cyclosporine
3
Biopsy
3
Vorinostat
2
Specimen Handling
2
Rituximab
2
Methotrexate
2
Etoposide
2
Cytarabine
2
Antilymphocyte Serum
2
thymoglobulin
1
pegylated granulocyte colony-stimulating factor
1
merphos
1
ivosidenib
1
decitabine and cedazuridine drug combination
1
cedazuridine
1
Thiotepa
1
TAK-243
1
Stem Cell Transplantation
1
Sirolimus
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Anemia, Refractory, with Excess of Blasts
×
aldesleukin
×
90 days
×
Clear all
No trials found.